Click Here! Click Here!
Click Here!

Factors affecting breast cancer outcomes: Can we do better?

Two decades in review: Progress in the treatment of mCRPC

Search archive       

We welcome your letters and suggestions for future articles.

Please address correspondence to Susan Usher, Editor,

  Back to Top of Page


Highlights from asco, CUA, AUA, CAPO and CAMO annual meetings

improving survival in metastatic prostate cancer

cetuximab and bevacizumab extend overall survival in mcrc

small renal masses

improving confidence in active surveillance

the needs of younger women with breast cancer

hematopoietic stem cell transplantation

body image disturbance and sexuality following treatment for breast cancer

assessing a transition care clinic

Biomarker testing and timeliness of treatment for lung cancer

acid suppressors and tki absorption

more trial summaries from CAMO

Click Here! Click Here!
© Parkhurst Publishing 2004-2013
ISSN 1925-7155
Privacy Statement
Legal Terms of Use